Skip to main content
Log in

Thrombosis and severe asthenia as priority manifestations in paroxysmal nocturnal haemoglobinuria

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Takeda J, Miyata T, Kawagoe K et al (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703–711

    Article  PubMed  CAS  Google Scholar 

  2. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV (1995) Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 333:1253–1258

    Article  PubMed  CAS  Google Scholar 

  3. Parker C, Omine M, Richards S et al (2005) Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 106:3699–3709

    Article  PubMed  CAS  Google Scholar 

  4. Rother RP, Bell L, Hillmen P, Gladwin MT (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma haemoglobin: a novel mechanism of human disease. JAMA 293:1653–1662

    Article  PubMed  CAS  Google Scholar 

  5. Hillmen P, Young NS, Schubert J et al (2006) The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 355:1233–1243

    Article  PubMed  CAS  Google Scholar 

  6. Brodsky RA, Young NS, Antonioli E et al (2008) Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood 111:1840–1847

    Article  PubMed  CAS  Google Scholar 

  7. Brodsky RA (2005) Paroxysmal nocturnal hemoglobinuria. In: Hoffman R, Benz EJ, Sattil SJ et al (eds) Hematology. Basic principles and practice, 4th edn. Elsevier, Philadelphia, pp 419–427

    Google Scholar 

  8. Rachidi S, Musallam KM, Taher AT (2010) A closer look at paroxysmal nocturnal hemoglobinuria. Eur J Intern Med 21(4):260–267

    Article  PubMed  Google Scholar 

  9. Hill A, Muus P, Dührsen U et al (2008) Improvement in fatigue with eculizumab treatment of patients with paroxysmal nocturnal hemoglobinuria(PNH) occurs independent of changes in anemia. Haematologica 93(1):359, Abstract 0903

    Google Scholar 

  10. Bessler M, Schrezenmeier H, Maciejewski JP et al (2007) Significant disease burden in paroxysmal nocturnal hemoglobinuria patients with lower levels of hemolysis, mild anemia and minimal transfusion: clinical improvement with eculizumab therapy. Blood 16:110, Abstract 840

    Google Scholar 

  11. Meyers G, Weitz I, Lamy T et al (2007) Disease related symptoms reported across a broad population of patients with paroxysmal nocturnal hemoglobinuria. Blood 16:110, Abstract 1076A

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. A. González.

Rights and permissions

Reprints and permissions

About this article

Cite this article

González, F.A., Villegas, A., Osorio, S. et al. Thrombosis and severe asthenia as priority manifestations in paroxysmal nocturnal haemoglobinuria. Ann Hematol 91, 1495–1496 (2012). https://doi.org/10.1007/s00277-012-1433-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-012-1433-2

Keywords

Navigation